RS2267161 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Sulfatide (d18:1/16:0(OH) levels) levels | T | OR: 0.3 | 1E-37 | PubMed |
| Sulfatide (d18:1/16:0) levels | T | OR: 0.29 | 1E-33 | PubMed |
| Total Sulfatide levels | T | OR: 0.25 | 3E-27 | PubMed |
| Sulfatide (d18:1/16:0) levels | T | OR: 0.23 | 2E-21 | PubMed |
| Pallidum iron levels (quantitative susceptibility mapping) | C | β: 0.064 | 3E-21 | PubMed |
| Sulfatide (d18:1/24:0(OH) levels) levels | T | OR: 0.22 | 4E-21 | PubMed |
| Sulfatide (d18:1/16:0(OH) levels) levels | T | OR: 0.22 | 5E-21 | PubMed |
| IDP dMRI TBSS ICVF Splenium of corpus callosum | T | β: 0.09 | 2E-17 | PubMed |
| IDP dMRI TBSS ICVF Cerebral peduncle R | T | β: 0.087 | 3E-16 | PubMed |
| Corpus callosum fractional anisotropy (splenium) | — | — | 4E-16 | PubMed |
| Brain morphology (MOSTest) | — | — | 5E-16 | PubMed |
| Pallidum iron levels (R2* MRI) | C | β: 0.055 | 2E-15 | PubMed |
| Corpus callosum fractional anisotropy (MOSTest) | — | — | 2E-15 | PubMed |
| Sulfatide (d18:1/24:0(OH) levels) levels | T | OR: 0.19 | 2E-15 | PubMed |
| IDP dMRI ProbtrackX ICVF cst l | T | β: 0.084 | 2E-15 | PubMed |
| IDP dMRI ProbtrackX ICVF cst r | T | β: 0.083 | 4E-15 | PubMed |
| wg lh intensity-contrast inferiorparietal | T | β: 0.082 | 6E-15 | PubMed |
| Total corpus callosum volume | — | — | 6E-15 | PubMed |
| wg rh intensity-contrast lateraloccipital | T | β: 0.082 | 9E-15 | PubMed |
| wg rh intensity-contrast inferiortemporal | T | β: 0.081 | 2E-14 | PubMed |